berberine and su 11248

berberine has been researched along with su 11248 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dai, B; Liu, R; Ma, Y; Wang, W; Zhan, Y; Zhang, D; Zhang, Y1
Li, C; Qiu, S; Sun, J; Wang, X; Wu, W; Xing, J; Xu, Y; Yan, W; Zhang, J; Zhang, Z1

Other Studies

2 other study(ies) available for berberine and su 11248

ArticleYear
Dihydroberberine exhibits synergistic effects with sunitinib on NSCLC NCI-H460 cells by repressing MAP kinase pathways and inflammatory mediators.
    Journal of cellular and molecular medicine, 2017, Volume: 21, Issue:10

    Topics: A549 Cells; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Berberine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Indoles; Inflammation Mediators; Lung Neoplasms; MAP Kinase Signaling System; Mice, Inbred NOD; Mice, SCID; Pyrroles; Sunitinib; Tumor Burden; Xenograft Model Antitumor Assays

2017
Berberine attenuates sunitinib-induced cardiac dysfunction by normalizing calcium regulation disorder via SGK1 activation.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2023, Volume: 175

    Topics: Animals; Berberine; Calcium; Cardiotoxicity; Heart Diseases; Humans; Mice; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Rats; Sunitinib

2023